PMID: 11472075 Adams GR, McCue SA
eligible Medicare patients can access FDA-approved GLP-1 medications for $50/month through the CMS Medicare GLP-1 Bridge Program - a different pathway worth evaluating before enrolling in a cash-pay compounded program FDA adverse event data (as of May 21, 2026): FDA had received more than 1,700 adverse events associated with compounded semaglutide and tirzepatide combined - a safety signal not specific to Omzo but material context for any compounded GLP-1 enrollment decision
Shojaei, M., Djalali, M., Khatami, M., Siassi, F
semaglutide side effects Some common side effects of tirzepatide include: Nausea Vomiting Abdominal pain Decreased appetite Dizziness Indigestion/upset stomach Injection site reactions (rash, itching) Some common side effects of semaglutide may include: Vomiting Diarrhea Abdominal pain Indigestion or heartburn Dizziness Bloating The most commonly reported side effects of either medication are gastrointestinal (GI) in nature
This BPC-157 TB-500 blend provides researchers with both compounds at a fixed 1:1 ratio in a single verified vial
A maintenance plan will be discussed to sustain your results.